White House coronavirus response coordinator Deborah Birx, MD, said labs don’t have the resources to operate Abbott’s m2000 RealTime System, which is the machine used to run the diagnostic tests.
So far, labs have only run 88,000 of Abbott’s tests in the last three weeks, according to MedTech Dive.
A spokesperson for Abbott told MedTech Dive the machines are used in hospitals and labs across the country and that the machines each run up to 470 tests in 24 hours, but the equipment is not being operated anywhere close to its full capacity because labs need more staff and supplies.
“We understand that some of these labs are working to expand their capacity by increasing staff and supplies to run more shifts,” an Abbott spokesperson told MedTech Dive. “In some instances states and cities are working to establish ways to send the samples to the labs that have capacity.”
Dr. Birx said she was scheduled to speak with lab directors to discuss how to address issues with running the tests at full capacity.
The American Clinical Laboratory Association has said for weeks that labs across the country face staffing and supply shortages that could hinder their ability to conduct COVID-19 diagnostic tests, according to MedTech Dive.
Read the full article here.
More articles on supply chain:
US Customs to seize exports of medical supplies
HHS contracts Philips to make 43,000 ventilators for $646M
The national stockpile is now empty, HHS says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
